Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Last 12 months price action with 12-month analyst target path
As of May 6, 2026, PotlatchDeltic Corporation (PCH) has a Wall Street consensus price target of $51.00, based on estimates from 13 covering analysts. With the stock currently trading at $41.73, this represents a potential upside of +22.2%. The company has a market capitalization of $3.23B.
Analyst price targets range from a low of $45.00 to a high of $57.00, representing a 24% spread in expectations. The median target of $51.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 4 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 3 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, PCH trades at a trailing P/E of 149.0x and forward P/E of 53.8x. Analysts expect EPS to grow -6.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $41.73, with bear and bull scenarios of $11.70 and $264.60 respectively. Model confidence stands at 43/100, suggesting limited visibility into future performance.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Welltower Inc..
Start ComparisonQuick answers to the most common questions about buying PCH stock.
The consensus Wall Street price target for PCH is $51, representing 22.2% upside from the current price of $41.73. With 13 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
PCH has a consensus rating of "Hold" based on 13 Wall Street analysts. The rating breakdown is mixed, with 6 Hold ratings making up the largest segment. The consensus 12-month price target of $51 implies 22.2% upside from current levels.
At a forward P/E of 53.8035x, PCH trades at a premium valuation. The consensus price target of $51 (22.2% upside) suggests analysts still see growth justifying the multiple.
The most bullish Wall Street analyst has a price target of $57 for PCH, while the most conservative target is $45. The consensus of $51 represents the median expectation. Our quantitative valuation model projects a bull case target of $265 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
PCH is moderately covered, with 13 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 6 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month PCH stock forecast based on 13 Wall Street analysts shows a consensus price target of $51, with estimates ranging from $45 (bear case) to $57 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $42, with bear/bull scenarios of $12/$265.
Our quantitative valuation model calculates PCH's fair value at $42 (base case), with a bear case of $12 and bull case of $265. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 43/100.
PCH trades at a forward P/E ratio of 53.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 149.0x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on PCH, with a "Hold" consensus rating and $51 price target (22.2% upside). 4 of 13 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
PCH analyst price targets range from $45 to $57, a 24% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $51 consensus represents the middle ground. Our model's $12-$265 range provides an independent fundamental perspective.